Page last updated: 2024-08-24

geranylgeraniol and Carcinoma, Anaplastic

geranylgeraniol has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
DeBose-Boyd, RA; Fernandes, NV; Katuru, R; Michon, R; Mo, H; Morris, LL; Yeganehjoo, H; Yu, ZL	1

Other Studies

1 other study(ies) available for geranylgeraniol and Carcinoma, Anaplastic

Article	Year
Geranylgeraniol suppresses the viability of human DU145 prostate carcinoma cells and the level of HMG CoA reductase. Experimental biology and medicine (Maywood, N.J.), 2013, Nov-01, Volume: 238, Issue:11 Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Diterpenes; Down-Regulation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Hydroxymethylglutaryl CoA Reductases; Male; Microscopy, Fluorescence; Prostatic Neoplasms	2013

Article

Year

Geranylgeraniol suppresses the viability of human DU145 prostate carcinoma cells and the level of HMG CoA reductase.

Experimental biology and medicine (Maywood, N.J.), 2013, Nov-01, Volume: 238, Issue:11

Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Diterpenes; Down-Regulation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Hydroxymethylglutaryl CoA Reductases; Male; Microscopy, Fluorescence; Prostatic Neoplasms

2013